SCHEMBL3846708

SCHEMBL3846708

CS(=O)(=O)c1ccc(-c2ncnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4F)cc23)s1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
KIT P10721 7/20 0.34
ALOX5AP P20292 6/20 0.32
FEN1 P39748 6/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
RXRA P19793 1/20 0.31
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
MAP4K4 O95819 1/20 0.31
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854489 0.93 PTGS2 (0.35) PTGS2KITCA12CA1CA2
SCHEMBL3846444 0.92 CA12 (0.33) PTGS1PTGS2KITALOX5APFEN1
SCHEMBL3849627 0.90 ALOX5AP (0.35) KITALOX5APFEN1
SCHEMBL3846505 0.89 PTGS2 (0.33) PTGS2KITPIK3CAMTORRXRA
SCHEMBL3852121 0.88 BRD4 (0.32) KITPIK3CAMTOR
SCHEMBL3854275 0.88 CYP3A4 (0.33) KITALOX5APFEN1CA12CA1
SCHEMBL3846261 0.87 CA12 (0.34) KITCA12CA1CA2CA9
SCHEMBL3853047 0.87 CA12 (0.32) CA12CA1CA2CA9PIK3CA
SCHEMBL3848501 0.86 CA12 (0.35) KITCA12CA1CA2CA9
SCHEMBL3851189 0.86 CA12 (0.32) CA12CA1CA2CA9MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed